{"transactions":[{"id":1325515,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":6000,"derivative":{"exercise_price":11.58,"expiration_date":"2030-03-11","underlying":"Common Shares","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325514,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":false,"shares":9334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":9334},"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325513,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":11510,"price":41.19,"value":474096.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.19 to $41.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325512,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":4490,"price":41.28,"value":185347.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on December 17, 2024 for purposes of net settlement calculations."}],"balance_after":11510,"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325511,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":11.58,"value":185280.0,"ownership":{"direct":true},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325510,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"sale","planned":false,"acquired":false,"shares":7199,"price":41.23,"value":296814.77,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325509,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":2135,"price":41.28,"value":88132.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on December 17, 2024 for purposes of net settlement calculations."}],"balance_after":7199,"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1325508,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-12-19T18:57:42.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":true,"shares":9334,"price":9.44,"value":88112.96,"ownership":{"direct":true},"balance_after":9334,"source":{"system":"sec-edgar","filing":"0000950170-24-138629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024138629/ownership.xml","form_type":"4"}},{"id":1581573,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-12T18:41:06.000Z","date":"2024-03-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":100000,"derivative":{"exercise_price":44.37,"expiration_date":"2034-03-10","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-030245","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000095017024030245/ownership.xml","form_type":"4"}},{"id":1954475,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-14T16:25:54.000Z","date":"2023-03-10","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":120000,"derivative":{"exercise_price":34.18,"expiration_date":"2033-03-09","underlying":"Common Shares","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-23-018467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919123018467/doc4.xml","form_type":"4"}},{"id":2164284,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":6511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.75,"expiration_date":"2028-03-11","underlying":"Common Shares","underlying_shares":6511},"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164283,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":2292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.1,"expiration_date":"2027-10-22","underlying":"Common Shares","underlying_shares":2292},"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164282,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":8.4,"expiration_date":"2027-03-12","underlying":"Common Shares","underlying_shares":813},"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164281,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":32,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.49,"expiration_date":"2026-03-10","underlying":"Common Shares","underlying_shares":32},"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164280,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164279,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":15355,"price":39.57,"value":607597.35,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The \"Amount\" and \"Price\" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.50 to $39.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164278,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":3293,"price":39.53,"value":130172.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the closing price of the Company's common shares on September 1, 2022 for purposes of net settlement calculations."}],"balance_after":15355,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164277,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":6511,"price":4.75,"value":30927.25,"ownership":{"direct":true},"balance_after":18648,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164276,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":2292,"price":3.1,"value":7105.2,"ownership":{"direct":true},"balance_after":12137,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164275,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":813,"price":8.4,"value":6829.2,"ownership":{"direct":true},"balance_after":9845,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164274,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":32,"price":7.49,"value":239.68,"ownership":{"direct":true},"balance_after":9032,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2164273,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-09-07T16:26:53.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":9000,"price":9.44,"value":84960.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-22-049015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122049015/doc4.xml","form_type":"4"}},{"id":2335747,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T16:11:12.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2023 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":125000,"derivative":{"exercise_price":30.01,"expiration_date":"2032-03-09","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-018445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919122018445/doc4.xml","form_type":"4"}},{"id":2683706,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":84896,"kind":"person","name":"AULIN SHERRY","position":1,"cik":"0001862144","reported_name":"AULIN SHERRY","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-03T16:42:37.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on the one year anniversary of the grant date, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on\nthe last day of each month."}],"balance_after":100000,"derivative":{"exercise_price":18.56,"expiration_date":"2031-06-02","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-037692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862144/000120919121037692/doc4.xml","form_type":"4"}}]}